SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-16-014598
Filing Date
2016-08-01
Accepted
2016-08-01 17:27:27
Documents
5
Period of Report
2016-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2229334z8-k.htm 8-K 32907
2 EX-3.1 a2229334zex-3_1.htm EX-3.1 41761
3 EX-3.2 a2229334zex-3_2.htm EX-3.2 144521
4 EX-3.3 a2229334zex-3_3.htm EX-3.3 166709
5 EX-10.1 a2229334zex-10_1.htm EX-10.1 164815
  Complete submission text file 0001047469-16-014598.txt   552153
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37841 | Film No.: 161798334
SIC: 2834 Pharmaceutical Preparations